Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06352125 · ClinicalTrials.gov registry record
An Observational Trial to Assess the Performance of the TEG® 6s Diagnostic System With the Citrated K, KH, RTH, FFH Cartridge
A clinical trial, sponsored by Haemonetics Corporation.
- Completed
- Registry status
- 338
- Enrollment target
NCT06352125 is a clinical trial that has completed, run by Haemonetics Corporation. The registered enrollment target is 338 participants.
The verdict
NCT06352125 has completed, sponsored by Haemonetics Corporation.
- COMPLETED
- Registry status
- 338 participants
- Enrollment target
Study Summary
This clinical trial is designed to assess the agreement of the TEG® 6s system using the Citrated K, KH, RTH, FFH, cartridge (hereafter referred to as the Heparin Neutralization (HN) Cartridge) with its comparators.
Interventions
- DIAGNOSTIC_TEST Clauss Fibrinogen
- DIAGNOSTIC_TEST TEG 6s Citrated K, KH, RTH, FFH Cartridge
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 338 participants |
| Start Date | 2021-12-09 |
| Est. Completion | 2023-01-31 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06352125
The ClinicalTrials.gov registry entry for NCT06352125 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 338 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Haemonetics Corporation, which has 11 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Clauss Fibrinogen is the first listed.
NCT06352125 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT06352125 about?
NCT06352125 is a clinical study titled "An Observational Trial to Assess the Performance of the TEG® 6s Diagnostic System With the Citrated K, KH, RTH, FFH Cartridge". This clinical trial is designed to assess the agreement of the TEG® 6s system using the Citrated K, KH, RTH, FFH, cartridge (hereafter referred to as the Heparin Neutralization (HN) Cartridge) with its comparators.
What is the current status of trial NCT06352125?
This trial is currently completed. The enrollment target is 338 participants. The study started on 2021-12-09. Estimated completion is 2023-01-31.
What interventions are being tested in trial NCT06352125?
The interventions under investigation include: Clauss Fibrinogen (DIAGNOSTIC_TEST), TEG 6s Citrated K, KH, RTH, FFH Cartridge (DIAGNOSTIC_TEST).
Who is sponsoring clinical trial NCT06352125?
This trial is sponsored by Haemonetics Corporation, which has 11 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.